InvestorsHub Logo
Followers 0
Posts 30
Boards Moderated 0
Alias Born 07/26/2017

Re: None

Monday, 08/21/2017 10:59:33 PM

Monday, August 21, 2017 10:59:33 PM

Post# of 65771
Small dip in revenues expected w/planting season underway for the quarter, (Apr May Jun) the advisory/consulting revs will always be dippy quarter on quarter as they're reliant on states opening up marketplaces. The business model was never in question. Its managements inability to raise equity capital from institutional and retail investors and the 6 odd pages in the Q devoted to all the toxic garbage notes they've taken diluting shareholders. There is no excuse for this. Unless the company can get their corporate house in order with regard to share structure and a management team who can deliver financials on time for once and deliver significant equity investment from friendly institutional investors on board for the long haul growth - none of the goodwill of the sector and the play is going to keep investors interest for very long. The fact that with all this dilution and being the single dominant public company player in the cannabis testing sector the company has apparently no interest in engaging an Investor Relations firm to date to communicate their story and engage new shareholders really begs the question if they have any idea what they are doing.